Ligand Pharmaceuticals Inc. and Pharmacopeia, Inc. to Present At the Oppenheimer 19th Annual Healthcare Conference

PRINCETON, N.J., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq:LGND) and Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that John L. Higgins, President and Chief Executive Officer of Ligand, and Dr. Joseph A. Mollica, Interim President and Chief Executive Officer of Pharmacopeia, will deliver a presentation at the Oppenheimer 19th Annual Healthcare Conference. Recently, Ligand and Pharmacopeia entered into a definitive merger agreement, under which Ligand will acquire Pharmacopeia.

Back to news